The epigenetic signatures and mutational landscape of the original tumors, such as p53, NRAS, BRAF, and other oncogenic drivers frequently found in skin cancers, are preserved in patient-derived organoids [141,142,143,144]. The gene discussed is TP53; the disease is skin cancer.